| Title |
Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
|
|---|---|
| Published in |
Diabetologia, February 2015
|
| DOI | 10.1007/s00125-015-3497-8 |
| Pubmed ID | |
| Authors |
Marjolein M. J. Zanders, Harm R. Haak, Myrthe P. P. van Herk-Sukel, Lonneke V. van de Poll-Franse, Jeffrey A. Johnson |
| Abstract |
Adherence to glucose-lowering drug (GLD) treatment regimens is crucial for metabolic control and improving prognosis. Because a diagnosis of cancer might have an impact on adherence to medication, this study explored changes in adherence to GLDs following a cancer diagnosis. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 10 | 20% |
| Student > Ph. D. Student | 8 | 16% |
| Student > Master | 7 | 14% |
| Researcher | 6 | 12% |
| Student > Doctoral Student | 4 | 8% |
| Other | 5 | 10% |
| Unknown | 9 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 27% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 18% |
| Nursing and Health Professions | 4 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Agricultural and Biological Sciences | 2 | 4% |
| Other | 9 | 18% |
| Unknown | 10 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 78. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2017.
All research outputs
#460,840
of 22,786,691 outputs
Outputs from Diabetologia
#238
of 5,034 outputs
Outputs of similar age
#6,591
of 352,514 outputs
Outputs of similar age from Diabetologia
#6
of 52 outputs
Altmetric has tracked 22,786,691 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,034 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,514 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.